Related Experiment Video

Updated: Apr 19, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

6.5K

Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review)

Asghar Ghasemi1, S Khalifi2, S Jedi1

  • 1Shahid Beheshti University of Medical Sciences Endocrine Physiology Research Center, Research Institute for Endocrine Sciences 24 Parvaneh street Velenjak, Tehran Iran PO box: 19395-4763 Shahid Beheshti University of Medical Sciences Endocrine Research Center, Research Institute for Endocrine Sciences Tehran Iran.

Acta Physiologica Hungarica
|December 24, 2014
PubMed

Insights

This study reviews a common rat model for type 2 diabetes, induced by streptozotocin and nicotinamide. It examines the model

Area of Science:

  • Endocrinology and Metabolism
  • Pharmacology
  • Animal Models of Disease

Background:

  • Diabetes mellitus is a global health crisis, with type 2 diabetes being the most prevalent form.
  • Effective diabetes management strategies with minimal side effects remain a significant clinical challenge.
  • Animal models are crucial for diabetes research due to limitations in human studies.

Purpose of the Study:

  • To provide an overview of the streptozotocin-nicotinamide induced rat model for type 2 diabetes.
  • To evaluate the advantages and disadvantages of this specific rodent model for human diabetes research.

Main Methods:

  • Literature review of studies utilizing the streptozotocin-nicotinamide rat model.
  • Analysis of the model's induction process, physiological characteristics, and relevance to human type 2 diabetes.

Main Results:

  • The streptozotocin-nicotinamide model replicates key features of human type 2 diabetes.
  • The model offers insights into disease mechanisms and potential therapeutic interventions.
  • Specific advantages and limitations for translational research are identified.

Conclusions:

  • The streptozotocin-nicotinamide rat model is a valuable tool for investigating type 2 diabetes.
  • Understanding its strengths and weaknesses is essential for effective application in diabetes research.
  • This model aids in the development of novel diabetes management strategies.
Keywords:
animal modelnicotinamideratstreptozotocintype 2 diabetes

More Related Videos

An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models10:27

An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models

Published on: October 20, 2017

8.0K
Retinal Pathophysiological Evaluation in a Rat Model09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

5.4K

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
2
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
1
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.9K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
999